Table 2.

Correlation of high NNMT expression with clinical attributes in gastric cancer

Groups	NO.	NNMT		Pearson χ2	P-value
		High no.	%
Gender				3.832	0.061
Male	464	246	53.0
Female	153	95	62.1
Age				1.978	0.161
≤60 years	247	128	51.8
>60 years	370	213	57.6
Histological type				4.431	0.351
Tubular	512	300	57.6
Hybrid	7	3	42.9
Mucinous	28	11	39.3
Signet ring cell	21	11	52.4
Othersa	13	8	61.5
Differentiation				5.066	0.079
High	32	12	37.5
Moderate	157	87	55.4
Low	383	222	58
Othersb
Primary tumor size				33.468	<0.001*
Tis	33	17	21.2
T1	62	28	45.2
T2	120	55	45.8
T3	345	214	62
T4	48	34	70.8
Lymph node metastasis				33.486	<0.001*
N0	238	101	42.4
N1	108	60	55.6
N2	117	74	63.2
N3	145	103	71
Distant metastasis				9.130	0.002*
M0	580	312	53.8
M1	38	30	78.9
TNM stage				46.134	<0.001*
0	34	9	26.5
I	119	44	37.0
II	200	112	56.0
III	217	143	65.9
IV	38	30	78.9
Preoperative CEA, ng/ml				2.517	0.284
≤5	263	136	51.7
>5	74	44	59.5
Unknown	281	162	57.7
Preoperative CA199, U/ml				2.590	0.274
≤37	276	143	51.8
>37	50	30	60
Unknown	292	169	57.9

^* P<0.05;

^aothers: papillary adenocarcinoma, 4 cases; adeno-squamous carcinoma, 4 cases; squamous cell carcinoma, 2 cases; undifferentiated carcinoma, 2 cases; neuroendocrine carcinoma, 1 case.

^bothers: tumors other than tubular or papillary adenocarcinomas.